New York Life Ventures

What New York Life Ventures does

New York Life Ventures (NYL Ventures) is the corporate venture capital arm of New York Life Insurance Company, founded in 2012 and headquartered at 51 Madison Avenue, New York. The firm invests in technology startups across fintech, insurtech, enterprise software, and adjacent categories such as digital health and proptech, deploying capital from seed through growth stages. NYL Ventures manages $1B+ in assets under management and has executed more than 300 proof-of-concept engagements, positioning its model as a hybrid of financial investor and strategic operating partner rather than a pure financial sponsor.

The firm is led by Joel Albarella (Head) and staffed by a 15+ person team with dedicated Heads of Investments, Platform, Innovation Services, and Business Development. Its portfolio spans roughly 30+ named companies, with a discernible thematic tilt toward AI infrastructure and applied AI in regulated workflows: voice AI (Vapi), legal/compliance AI (Norm Ai), workflow AI (Scribe), machine learning automation (DataRobot, H2O.ai), AI software development (Blitzy), AI procurement (Levelpath), and AI model risk management (ValidMind). Other holdings span insurance distribution (Modern Life, SimplyInsured, SmartAsset), benefits and health (Empathy, Wellth, Propel, Advocate), data infrastructure (Crusoe, Strata, Latica, Kingfield), and consumer fintech (Affirm, Alto IRA, SigFig, Kasa).

NYL Ventures generates returns primarily through equity investments in portfolio companies rather than product or licensing revenue. The firm is a strategic CVC within a mutual insurer parent that reported $807.7B in assets under management as of December 2025, giving NYL Ventures access to permanent patient capital and the ability to facilitate balance-sheet partnerships between portfolio companies and the parent — exemplified by New York Life's commitment to purchase up to $750M in Affirm installment loans through 2026. Its go-to-market is direct, relationship-driven deal sourcing via the parent network, with distribution to portfolio companies measured in capital, proof-of-concept access, and enterprise partnership rather than product sales channels.

Name

New York Life Ventures

Legal name

New York Life Insurance Company

Website

https://nylventures.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

NYL Ventures is the corporate venture capital arm of New York Life Insurance Company, deploying $1B+ in assets into seed-through-growth technology startups across fintech, insurtech, enterprise software, and AI. The firm combines capital investment with strategic partnership, offering portfolio companies access to 300+ proof-of-concept programs and New York Life's enterprise distribution network.

Ownership category

akta.pro rank

Product category

Corporate Venture Capital

NAICS

Other Financial Investment Activities (5239), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Life Insurance (6311)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

akta.pro secondary industry

Late-Stage Venture Capital (Series C+) (FSANAAAC)

Keywords

• Corporate venture capital
• Venture capital investing
• Fintech investments
• Insurtech investments
• Enterprise software investing

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Venture Capital Investment Returns: NYL Ventures generates returns through equity investments in early-stage to growth-stage technology startups. The fund has achieved $1 billion+ in assets under management and has completed over 300 proof of concept tests with portfolio companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

New York Life Ventures is the corporate venture capital arm of New York Life Insurance Company, providing equity capital and strategic partnership to innovative technology startups across Fintech, Insurtech, Enterprise Software, Digital Health, and Proptech from seed through growth stages. The firm pairs capital with a Proof of Concept program that runs pilots against New York Life's enterprise operations and distribution, and has executed 300+ POCs while managing over $1 billion in assets.

Product overview

New York Life Ventures is a corporate venture capital firm that provides investment and partnership to early and growth-stage technology companies. Rather than a unified software product, the organization operates a portfolio investment model across four focus areas: Fintech, Insurtech, Enterprise Software, and adjacent categories including Digital Health and Proptech. The portfolio includes companies at various stages, from seed investments to mature companies. Notable portfolio products span AI-powered platforms including Vapi (voice AI agents), Norm Ai (regulatory compliance AI), Scribe (workflow documentation), DataRobot (machine learning automation), and H2O.ai (open-source ML platform), among others in insurance, data management, procurement, and financial services sectors.

Differentiator

Problem solved

Functional benefit

Products and services

• NYL Ventures Investment Platform
• Proof of Concept (POC) Program

Quantifiable outcome

• 300+ proof of concepts completed
• +2 more outcomes

Named customers10 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Norm AiflagshipStrategic or Co-development Partner · 1 January 2024New York Life and Norm Ai partnered to transform compliance using AI. Norm Ai builds regulatory AI agents to support compliance processes and establish AI guardrails for financial services.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Northwestern Mutual Future Ventures: The CVC arm of Northwestern Mutual, a top-10 US life insurer, investing in fintech, insurtech, and digital health startups. Most direct comparable: peer-mutual life insurer CVC, co-invested alongside NYL Ventures in Modern Life's Series A, and operates a similar capital-plus-partnership model targeting financial services transformation.
• MassMutual Ventures: CVC arm of Massachusetts Mutual Life Insurance, investing in fintech, insurtech, enterprise software, and digital health. Closely comparable to NYL Ventures in sector focus, stage range (seed to growth), and strategic partnership model with a mutual life-insurance parent.
• MetLife Ventures: CVC arm of MetLife focused on insurtech, fintech, and adjacent digital transformation. Comparable in mission (corporate-backed VC at a top-tier life insurer) and in emphasis on solutions that can be deployed across the parent carrier's distribution and operations.
• Prudential Ventures: CVC of Prudential Financial investing across insurtech, fintech, health, and asset-management tech. Comparable strategic posture: corporate balance-sheet capital, multi-stage investing, and active pilots with the parent carrier to accelerate distribution or product innovation.
• Citi Ventures: CVC arm of Citigroup investing in fintech, enterprise software, and insurtech adjacencies. Comparable as a diversified financial-services CVC with global scope and a model of equity plus commercial deployment across the parent bank's distribution.
• Munich Re Ventures: CVC arm of Munich Re, the global reinsurer, investing in insurance technology, climate, mobility, and AI. Comparable as a re/insurance-balance-sheet investor with strategic pilots and product-validation capabilities for portfolio companies.
• Manulife Capital: Investment and venture arm of Manulife, the global life insurer. Comparable as a top-tier life-insurance balance-sheet investor targeting fintech, insurtech, and digital health with a long-duration, patient-capital posture.
• AXA Strategic Ventures: CVC arm of AXA focused on insurance innovation, fintech, and emerging tech. Comparable as a global life/P&C insurance CVC running multi-stage investments and proof-of-concept programs with the parent's business units.
• Transamerica Ventures: CVC of Transamerica (Aegon) investing in insurance, asset management, and health tech. Comparable in life-insurance CVC posture and focus on innovations that can be integrated into the parent carrier's products and distribution.
• Liberty Mutual Strategic Ventures: CVC of Liberty Mutual, the large P&C insurer, investing in insurtech, mobility, and enterprise software. Comparable as a major-insurance-balance-sheet CVC with a POC/pilot-driven partnership model and multi-stage approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/showcase/new-york-life-ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments34 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New York Life Ventures